β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity

Bioorganic & Medicinal Chemistry
2010.0

Abstract

The physiological role of aryl hydrocarbon receptor (AhR) is not yet fully understood, and investigation is hampered by the limited solubility of reported AhR ligands in aqueous media. To achieve improved solubility, we focused on our previous finding that planarity-disruption of molecules leads to less efficient crystal packing and greater aqueous solubility. Here, we describe chemical modification of an AhR agonist, beta-naphthoflavone, focusing on planarity-disruption. As expected, introduction of substituents at the ortho-positions of the phenyl group resulted in greater solubility. Among the compounds prepared, the fluoro analog showed more potent AhR agonistic activity and greater solubility than did beta-naphthoflavone. Our results indicate that this strategy to improve aqueous solubility, that is, introduction of substituent(s) that disrupt planarity, may be generally applicable to bicyclic molecules.

Knowledge Graph

Similar Paper

β-Naphthoflavone analogs as potent and soluble aryl hydrocarbon receptor agonists: Improvement of solubility by disruption of molecular planarity
Bioorganic & Medicinal Chemistry 2010.0
Discovery of Norisoboldine Analogue III<sub>11</sub> as a Novel and Potent Aryl Hydrocarbon Receptor Agonist for the Treatment of Ulcerative Colitis
Journal of Medicinal Chemistry 2023.0
Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
An overview of aryl hydrocarbon receptor ligands in the Last two decades (2002–2022): A medicinal chemistry perspective
European Journal of Medicinal Chemistry 2022.0
Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone
Bioorganic &amp; Medicinal Chemistry 2019.0
Design and synthesis of a series of α-benzyl phenylpropanoic acid-type peroxisome proliferator-activated receptor (PPAR) gamma partial agonists with improved aqueous solubility
Bioorganic &amp; Medicinal Chemistry 2013.0
4-(3-Aryloxyaryl)quinoline alcohols are liver X receptor agonists
Bioorganic &amp; Medicinal Chemistry 2009.0
Discovery and optimization of a novel series of liver X receptor-α agonists
Bioorganic &amp; Medicinal Chemistry Letters 2006.0
Design, synthesis and pharmacology of 1,1-bistrifluoromethylcarbinol derivatives as liver X receptor β-selective agonists
Bioorganic &amp; Medicinal Chemistry Letters 2015.0
Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II
Journal of Medicinal Chemistry 2008.0